skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
01/07/2003
Application #:
08855280
Filing Dt:
05/13/1997
Inventors:
DARELL D. BIGNER, JOHN H. SAMPSON, DAVID M. ASHLEY, LAURA P. HALE
Title:
ALLOGENEIC CELLULAR VACCINE
Assignment: 1
Reel/Frame:
008836/0642Recorded: 12/02/1997Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/30/1997
Exec Dt:
10/30/1997
Exec Dt:
10/30/1997
Exec Dt:
10/30/1997
Assignee:
230 NORTH BUILDING
DURHAM, NORTH CAROLINA 27708
Correspondent:
BANNER & WITCOFF, LTD.
SARAH A. KAGAN
1001 G STREET, N.W., SUITE 1100
WASHINGTON, D.C. 20001-4597
Assignment: 2
Reel/Frame:
009550/0657Recorded: 11/04/1998Pages: 9
Conveyance:
CONFIRMATORY LICENSE
Assignor:
Exec Dt:
08/26/1998
Assignee:
EXTRAMURAL INVENTIONS OFFICE, THE, MSC 7750
6701 ROCKLEDGE DRIVE, ROOM 3188
BETHESDA, MARYLAND 20892
Correspondent:
THE NATIONAL INSTITUTES OF HEALTH
THE EXTRAMURAL INVENTIONS OFFICE
6701 ROCKLEDGE DRIVE, ROOM 3188
MSC 7750
BETHESDA, MARYLAND 20892-7750
Assignment: 3
Reel/Frame:
021174/0249Recorded: 06/30/2008Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/26/1998
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 06/03/2024 03:42 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT